Aclaris raises $27.5M via sale of 3.4M shares to Bain Capital affiliates

Aclaris Therapeutics, Inc.

Sold 3.4M shares of common stock for aggregate gross proceeds of $27.5M.
Shares purchased by entities affiliated with Bain Capital Life Sciences.
Sale executed under existing ATM agreement with SVB Securities and Cantor Fitzgerald.

item 7.01

Aclaris Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-040192

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.